Early Spectral Resolution Predicts Later Speech Recognition in Adult Cochlear Implant Recipients
The Laryngoscope · 2026-07 · 136 (7) · 3155-3164
DOI: 10.1002/lary.70383 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, online erschienen am 23.02.2026. Verfasst von Katelyn A Berg und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Cochlear Implants, Speech Perception, Deafness. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCD NIH HHS, National Institute on Deafness and Other Communication Disorders.
Abstract (Originalsprache)
Objectives
To investigate the trajectory of spectral resolution in adult cochlear implant ( CI ) recipients and determine whether early spectral resolution measures can predict later speech recognition outcomes.
Methods
Prospective, longitudinal study of 531 postlingually deafened adult CI recipients. Spectral resolution ( EasyQSMD ) and speech recognition ( CNC words, AzBio sentences in quiet and noise) were evaluated from activation through 1‐year post‐activation. Growth curve models were fit to EasyQSMD thresholds across all timepoints to generate mode‐based estimates of early spectral resolution at 1‐month post‐activation. These model‐derived early thresholds were then used to predict later speech recognition outcomes (best of 6‐months and 1‐year) through linear regression analyses.
Results
EasyQSMD thresholds improved from activation to 1‐week post‐activation, then stabilized through the first year. Model‐derived early EasyQSMD thresholds significantly predicted later speech recognition outcomes, explaining 3%–8% of the variance in performance.
Conclusion
Spectral resolution rapidly stabilizes, reaching asymptotic performance by 1‐week post‐activation. The EasyQSMD provides a non‐linguistic assessment tool that demonstrates significant predictive value for subsequent speech recognition outcomes. This early predictive capability enables the identification of poor performers during a critical window when speech recognition skills are still developing and the brain's neuroplasticity is at peak potential. Integrating spectral resolution assessment into early post‐activation clinical protocols could improve individualized realistic expectations counseling and guide targeted interventions—potentially leading to improved overall CI adoption rates. The brief administration time and independence from linguistic content make the EasyQSMD particularly valuable for multilingual populations and during the earliest stages of auditory rehabilitation post‐CI. Level of Evidence 3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Audiology, Hearts for Hearing Foundation, Oklahoma City, Oklahoma, USA.
- Department of Otolaryngology, Audiology Division, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Förderung
- NIDCD NIH HHS
- National Institute on Deafness and Other Communication Disorders
Zitieren
APA
Berg, K. A., Roberts, J. B., Burchesky, M. Z., & Gifford, R. H. (2026). Early Spectral Resolution Predicts Later Speech Recognition in Adult Cochlear Implant Recipients. The Laryngoscope, 136(7), 3155-3164. https://doi.org/10.1002/lary.70383
Vancouver
Berg KA, Roberts JB, Burchesky MZ, Gifford RH. Early Spectral Resolution Predicts Later Speech Recognition in Adult Cochlear Implant Recipients. The Laryngoscope. 2026;136(7):3155-3164. doi:10.1002/lary.70383
BibTeX
@article{Berg2026,
author = {Berg, Katelyn A and Roberts, Jillian B and Burchesky, Michael Z and Gifford, René H},
title = {Early Spectral Resolution Predicts Later Speech Recognition in Adult Cochlear Implant Recipients},
journal = {The Laryngoscope},
year = {2026},
volume = {136},
number = {7},
pages = {3155--3164},
doi = {10.1002/lary.70383}
}
EUVIMED